Bin Huang

Bin Huang

Auto-generated profile, based on publicly available information

Bin Huang

Department of Bioinformatics, Nanjing Medical University, Nanjing, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2022 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
LWLingxiang Wu
Lingxiang Wu
WWWei Wu
Wei Wu
JZJunxi Zhang
Junxi Zhang
ZZZheng Zhao
Zheng Zhao
LLLiangyu Li
Liangyu Li
QWQianghu Wang
Qianghu Wang
Isocitrate dehydrogenase (IDH) wild-type glioblastoma (GBM) has a dismal prognosis. A better understanding of tumor evolution holds the key to developing more effective treatment. Here we study GBM's natural evolutionary trajectory by using rare multifocal samples. We sequenced 61,062 single cells from eight multifocal IDH wild-type primary GBMs and defined a natural evolution signature (NES) of the tumor. We show that the NES significantly associates with the activation of transcription factors that regulate brain development, including MYBL2 and FOSL2. Hypoxia is involved in inducing NES transition potentially via activation of the HIF1A–FOSL2 axis. High-NES tumor cells could recruit and polarize bone marrow–derived macrophages through activation of the FOSL2–ANXA1–FPR1/3 axis. These polarized macrophages can efficiently suppress T-cell activity and accelerate NES transition in tumor cells. Moreover, the polarized macrophages could upregulate CCL2 to induce tumor cell migration. Significance: GBM progression could be induced by hypoxia via the HIF1A–FOSL2 axis. Tumor-derived ANXA1 is associated with recruitment and polarization of bone marrow–derived macrophages to suppress the immunoenvironment. The polarized macrophages promote tumor cell NES transition and migration. This article is highlighted in the In This Issue feature, p. 2711

9 January 2023 in Cancer Research
Verified
Journal Article
Open access
PDF file
MWMin Wu
Min Wu
LWLingxiang Wu
Lingxiang Wu
WWWei Wu
Wei Wu
MZMengyan Zhu
Mengyan Zhu
JLJianyu Li
Jianyu Li
QWQianghu Wang
Qianghu Wang
Tumor-associated macrophages (TAM) play a crucial role in immunosuppression. However, how TAMs are transformed into immunosuppressive phenotypes and influence the tumor microenvironment (TME) is not fully understood. Here, we utilized single-cell RNA sequencing and whole-exome sequencing data of glioblastoma (GBM) tissues and identified a subset of TAMs dually expressing macrophage and tumor signatures, which were termed double-positive TAMs. Double-positive TAMs tended to be bone marrow–derived macrophages (BMDM) and were characterized by immunosuppressive phenotypes. Phagocytosis of glioma cells by BMDMs in vitro generated double-positive TAMs with similar immunosuppressive phenotypes to double-positive TAMs in the GBM TME of patients. The double-positive TAMs were transformed into M2-like macrophages and drove immunosuppression by expressing immune-checkpoint proteins CD276, PD-L1, and PD-L2 and suppressing the proliferation of activated T cells. Together, glioma cell phagocytosis by BMDMs in the TME leads to the formation of double-positive TAMs with enhanced immunosuppressive phenotypes, shedding light on the processes driving TAM-mediated immunosuppression in GBM. Significance: Bone marrow–derived macrophages phagocytose glioblastoma cells to form double-positive cells, dually expressing macrophage and tumor signatures that are transformed into M2-like macrophages and drive immunosuppression.

1 November 2018 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
XGXiong-Bo Guo
Xiong-Bo Guo
BHBin Huang
Bin Huang
YPYing-Hua Pan
Ying-Hua Pan
SSShu-Guang Su
Shu-Guang Su
YLYan Li
Yan Li
Background: Establishment of cohesion 1 homolog 2 (ESCO2) plays important roles in the regulation of cohesion and genomic stability and has been implicated in human cancers. Yet, its clinical significance and biological function in colorectal cancer (CRC) are unknown. Methods: The expression of ESCO2 was examined by quantitative real-time PCR, Western blot, and immunohistochemistry. The role of ESCO2 in the tumor metastasis of CRC and the related mechanisms were investigated using in vitro and in vivo models. Results: In this study, we show that low expression of ESCO2 in CRC was closely correlated with lymphatic and distant metastasis. Patients with low ESCO2 expression experienced shorter overall survival and disease-free survival in two independent cohorts containing a total of 587 CRC cases. ESCO2 overexpression suppressed, whereas ESCO2 knockdown promoted cell migration in vitro and tumor metastasis in vivo via modulation of epithelial–mesenchymal transition (EMT) process. Mechanistically, ESCO2 inhibited the transcriptional activity of MMP2 promoter to downregulate its expression. Reexpression of MMP2 partially attenuated the ESCO2-mediated malignant phenotypes. Conclusion: Collectively, our data suggest that ESCO2 serves as a potential prognostic factor and exerts antimetastatic activity in CRC.

1 February 2022 in Bioengineered
Verified
Journal Article
Open access
GXGang Xiao
Gang Xiao
BHBin Huang
Bin Huang
Ming GuoMing Guo
Ming Guo
CLChaoxin Long
Chaoxin Long
PLPingan Li
Pingan Li
CGChuncheng Guan
Chuncheng Guan
BRCAT54 (also known as MRPS30 divergent transcript) is an anti-tumor long non-coding RNA (lncRNA) in lung cancer, while its role in vestibular schwannoma (VS) is unclear. We predicted that BRCAT54 could interact with microRNA (miR)-21, which suppresses VS cell proliferation. This study was then carried out to study the interaction between BRCAT54 and miR-21 in VS. A total of 56 VS samples and 42 normal vestibular nerve (VN) samples were included in this study. The expression of BRCAT54 and miR-21 in these samples were analyzed with RT-qPCR. Subcellular location of BRCAT54 in primary VS cells was analyzed by subcellular fractionation assay. The direct interaction between BRCAT54 and miR-21 was analyzed through RNA pull-down assay. Overexpression assay was performed to explore the interaction between BRCAT54 and miR-21. The role of BRCAT54 and miR-21 in primary VS cell proliferation was analyzed using BrdU assay. We found that BRCAT54 was downregulated in VS samples than that in VN samples, while miR-21 was upregulated in VS samples. BRCAT54 and miR-21 were not closely correlated. BRCAT54 was detected in both nuclear and cytoplasm samples, and BRCAT54 directly interacted with miR-21. However, BRCAT54 and miR-21 did not affect the expression of each other. BRCAT54 suppressed primary VS cell proliferation and inhibited the role of miR-21 in promoting cell proliferation. Therefore, BRCAT54 may sponge miR-21 to suppress cell proliferation in VS. GRAPHICAL ABSTRACT

4 April 2023
Verified
Other
Open access
LWLingxiang Wu
Lingxiang Wu
WWWei Wu
Wei Wu
JZJunxi Zhang
Junxi Zhang
ZZZheng Zhao
Zheng Zhao
LLLiangyu Li
Liangyu Li
QWQianghu Wang
Qianghu Wang
Supplementary Figure from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma

4 April 2023
Verified
Other
Open access
LWLingxiang Wu
Lingxiang Wu
WWWei Wu
Wei Wu
JZJunxi Zhang
Junxi Zhang
ZZZheng Zhao
Zheng Zhao
LLLiangyu Li
Liangyu Li
QWQianghu Wang
Qianghu Wang
Supplementary Table from Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma